Packaged Medicaments in   United States

Overview In August 2024 United States' Packaged Medicaments exports accounted up to $2.88B and imports accounted up to $7.49B, resulting in a negative trade balance of $4.6B. Between August 2023 and August 2024 the exports of United States'   Packaged Medicaments have decreased by $-495M (-14.7%) from $3.38B to $2.88B, while imports decreased by $-158M (-2.06%) from $7.64B to $7.49B.

Destinations In August 2024, Packaged Medicaments were exported mostly to Spain ($497M), Japan ($337M), Canada ($291M), China ($243M), and Netherlands ($151M), and were imported mostly from Switzerland ($1.16B), India ($875M), Italy ($737M), Ireland ($606M), and China ($586M).

Growth In August 2024, the decrease in Packaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to Netherlands ($-168M or -47.2%), Germany ($-47.9M or -46.7%), and Canada ($-24.2M or -9.39%). In August 2024, the decrease in Packaged Medicaments's year-by-year imports was explained primarily by a decrease in imports from Germany ($-119M or -16.8%), Belgium ($-36.5M or -25.5%), and Sweden ($-33.6M or -53.5%).